323 related articles for article (PubMed ID: 33728762)
21. Change of Health-Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure.
Sepehrvand N; Savu A; Spertus JA; Dyck JRB; Anderson T; Howlett J; Paterson I; Oudit GY; Kaul P; McAlister FA; Ezekowitz JA;
J Am Heart Assoc; 2020 Sep; 9(17):e017278. PubMed ID: 32812460
[TBL] [Abstract][Full Text] [Related]
22. Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.
Teramoto K; Tay WT; Tromp J; Katherine Teng TH; Chandramouli C; Ouwerkerk W; Lawson CA; Huang W; Hung CL; Chopra V; Anand I; Mark Richards A; Lam CSP
Circ Cardiovasc Qual Outcomes; 2023 Jan; 16(1):e009134. PubMed ID: 36484254
[TBL] [Abstract][Full Text] [Related]
23. Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.
Nagy KV; Merkely B; Rosero S; Geller L; Kosztin A; McNitt S; Polonsky B; Goldenberg I; Zareba W; Kutyifa V
Europace; 2019 Dec; 21(12):1865-1875. PubMed ID: 31617896
[TBL] [Abstract][Full Text] [Related]
24. Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study.
Stehlik J; Mountis M; Haas D; Palardy M; Ambardekar AV; Estep JD; Ewald G; Russell SD; Robinson S; Jorde U; Taddei-Peters WC; Jeffries N; Richards B; Khalatbari S; Spino C; Baldwin JT; Mann D; Stewart GC; Aaronson KD;
J Heart Lung Transplant; 2020 Jan; 39(1):27-36. PubMed ID: 31822442
[TBL] [Abstract][Full Text] [Related]
25. Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.
Greene SJ; Butler J; Spertus JA; Hellkamp AS; Vaduganathan M; DeVore AD; Albert NM; Duffy CI; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
JAMA Cardiol; 2021 May; 6(5):522-531. PubMed ID: 33760037
[TBL] [Abstract][Full Text] [Related]
26. Effect of a strategy of comprehensive vasodilation versus usual care on health-related quality of life among patients with acute heart failure.
Belkin M; Wussler D; Gualandro DM; Shrestha S; Strebel I; Goudev A; Maeder MT; Walter J; Flores D; Kozhuharov N; Lopez-Ayala P; Danier I; de Oliveira Junior MT; Kobza R; Rickli H; Breidthardt T; Erne P; Münzel T; Mueller C
ESC Heart Fail; 2021 Oct; 8(5):4218-4227. PubMed ID: 34355538
[TBL] [Abstract][Full Text] [Related]
27. Mapping the Kansas City Cardiomyopathy Questionnaire (KCCQ) Onto EQ-5D-3L in Heart Failure Patients: Results for the Japanese and UK Value Sets.
Hunger M; Eriksson J; Regnier SA; Mori K; Spertus JA; Cristino J
MDM Policy Pract; 2020; 5(2):2381468320971606. PubMed ID: 33344768
[No Abstract] [Full Text] [Related]
28. Interaction between the Kansas City Cardiomyopathy Questionnaire and the Pocock's clinical score in predicting heart failure outcomes.
Sawadogo K; Ambroise J; Vercauteren S; Castadot M; Vanhalewyn M; Col J; Robert A
Qual Life Res; 2016 May; 25(5):1245-55. PubMed ID: 26456163
[TBL] [Abstract][Full Text] [Related]
29. Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.
Stubblefield WB; Jenkins CA; Liu D; Storrow AB; Spertus JA; Pang PS; Levy PD; Butler J; Chang AM; Char D; Diercks DB; Fermann GJ; Han JH; Hiestand BC; Hogan CJ; Khan Y; Lee S; Lindenfeld JM; McNaughton CD; Miller K; Peacock WF; Schrock JW; Self WH; Singer AJ; Sterling SA; Collins SP
Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e007956. PubMed ID: 34555929
[TBL] [Abstract][Full Text] [Related]
30. Investigating gender-based differential item functioning on the Kansas City Cardiomyopathy Questionnaire (KCCQ) using qualitative content analysis.
Coles TM; Lucas N; McFatrich M; Henke D; Ridgeway JL; Behnken EM; Weinfurt K; Reeve BB; Corneli A; Dunlay SM; Spertus JA; Lin L; Piña IL; Bocell FD; Tarver ME; Dohse H; Saha A; Caldwell B
Qual Life Res; 2023 Mar; 32(3):841-852. PubMed ID: 36322269
[TBL] [Abstract][Full Text] [Related]
31. Does heart failure-specific health status identify patients with bothersome symptoms, depression, anxiety, and/or poorer spiritual well-being?
Flint KM; Fairclough DL; Spertus JA; Bekelman DB
Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):233-241. PubMed ID: 30649237
[TBL] [Abstract][Full Text] [Related]
32. Comparison Between the Kansas City Cardiomyopathy Questionnaire and New York Heart Association in Assessing Functional Capacity and Clinical Outcomes.
Hawwa N; Vest AR; Kumar R; Lahoud R; Young JB; Wu Y; Gorodeski EZ; Cho L
J Card Fail; 2017 Apr; 23(4):280-285. PubMed ID: 27940335
[TBL] [Abstract][Full Text] [Related]
33. Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction.
Butler J; Khan MS; Mori C; Filippatos GS; Ponikowski P; Comin-Colet J; Roubert B; Spertus JA; Anker SD
Eur J Heart Fail; 2020 Jun; 22(6):999-1005. PubMed ID: 32239794
[TBL] [Abstract][Full Text] [Related]
34. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Kosiborod MN; Jhund PS; Docherty KF; Diez M; Petrie MC; Verma S; Nicolau JC; Merkely B; Kitakaze M; DeMets DL; Inzucchi SE; Køber L; Martinez FA; Ponikowski P; Sabatine MS; Solomon SD; Bengtsson O; Lindholm D; Niklasson A; Sjöstrand M; Langkilde AM; McMurray JJV
Circulation; 2020 Jan; 141(2):90-99. PubMed ID: 31736335
[TBL] [Abstract][Full Text] [Related]
35. Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure.
Albarrati AM; Altimani R; Almogbel O; Alnahdi AH; Almurdi MM; Abuammah A; Nazer R
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003959
[No Abstract] [Full Text] [Related]
36. Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome.
Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
Int J Cardiol; 2018 Sep; 267():128-132. PubMed ID: 29957252
[TBL] [Abstract][Full Text] [Related]
37. Health status across major subgroups of patients with heart failure and preserved ejection fraction.
Siddiqi TJ; Anker SD; Filippatos G; Ferreira JP; Pocock SJ; Böhm M; Brueckmann M; Chopra VK; Iwata T; Januzzi J; Piña IL; Ponikowski P; Senni M; Vedin O; Verma S; Zhang Y; Zannad F; Packer M; Butler J
Eur J Heart Fail; 2023 Sep; 25(9):1623-1631. PubMed ID: 36974746
[TBL] [Abstract][Full Text] [Related]
38. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
[TBL] [Abstract][Full Text] [Related]
39. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
[TBL] [Abstract][Full Text] [Related]
40. Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: a mixed-methods study.
Rubio R; Palacios B; Varela L; Fernández R; Camargo Correa S; Estupiñan MF; Calvo E; José N; Ruiz Muñoz M; Yun S; Jiménez-Marrero S; Alcoberro L; Garay A; Moliner P; Sánchez-Fernández L; Soria Gómez MT; Hidalgo E; Enjuanes C; Calero-Molina E; Rueda Y; San Saturnino M; Garcimartín P; López-Ibor JV; Segovia-Cubero J; Comin-Colet J
BMJ Open; 2021 Dec; 11(12):e053216. PubMed ID: 34862295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
